Prostate cancer : science and clinical practice /

Bibliographic Details
Uniform Title:Prostate cancer (Mydlo)
Other Authors: Mydlo, Jack H. (Editor), Godec, Ciril J. (Editor)
Format: eBook
Language:English
Published: Amsterdam : Elsevier/Academic Press, [2016]
Edition:Second edition.
Subjects:
Online Access:Connect to the full text of this electronic book.
Table of Contents:
  • Population screening for prostate cancer and early detection
  • Inflammation and infection in the etiology of prostate cancer
  • Androgen receptor
  • Novel research on fusion genes and next-generation sequencing
  • Should Gleason score 6 still be called cancer?
  • High grade prostatic intraepithelial neoplasia and atypical glands
  • Prostate cancer in the elderly
  • Prostate cancer and other primary malignancies
  • Biopsy prophylaxis, technique, complications, and repeat biopsies
  • Total and free PSA, PCA3, PSA density and velocity
  • Imaging in localized prostate cancer
  • Prostate cancer prevention: strategies and realities
  • Prostate-specific antigen screening guidelines
  • Cancer of the prostate: incidence in the USA
  • International trends in prostate cancer
  • Race, ethnicity, marital status, literacy, and prostate cancer outcomes in the united states
  • Hereditary prostate cancer
  • Neuroendocrine prostate cancer
  • Breast and prostate cancers: a comparison of two endocrinologic malignancies
  • Heart healthy = prostate healthy and S.A.M. are the ideal "natural" recommendations for prostate cancer
  • Effects of smoking, alcohol, and exercise on prostate cancer
  • Environmental and occupational exposures and prostate cancer
  • Level-1 data from the reduce study and the PCPT data
  • Decision support for low-risk prostate cancer
  • Active surveillance: rationale, patient selection, follow-up, and outcomes
  • Preoperative risk assessment
  • Is surgery still necessary for prostate cancer?
  • Indications for pelvic lymphadenectomy
  • The surgical anatomy of the prostate
  • Radical retropubic prostatectomy
  • Radiation-resistant prostate cancer and salvage prostatectomy
  • Postradical prostatectomy incontinence
  • Prognostic significance of positive surgical margins and other implications of pathology report
  • Open versus robotic prostatectomy
  • The technique of robotic nerve-sparing prostatectomy
  • Anterior approach to robotic radical prostatectomy
  • Posterior approach to robotic-assisted laparoscopic radical prostatectomy
  • The technique of robotic nerve sparing prostatectomy: extraperitoneal approach
  • Clinical and pathologic staging of prostate cancer
  • Management of bladder neck contracture in the prostate cancer survivor
  • Reimbursement for prostate cancer treatment
  • Fundamentals of radiation treatment for prostate carcinoma
  • techniques, radiation biology, and evidence base
  • Radiation with hormonal therapy
  • Brachytherapy for prostate cancer: an overview
  • Intensity modulated radiotherapy and image guidance
  • Proton beam therapy
  • Radiotherapy after radical prostatectomy: adjuvant versus salvage approach
  • Emerging modalities in radiation therapy for prostate cancer
  • Management of PSA recurrences after radical prostatectomy
  • Salvage therapy for locally recurrent prostate cancer after external beam radiation therapy
  • Management of locally advanced (nonmetastatic) prostate cancer
  • Androgen deprivation therapy: appropriate patients, timing to initiate ADT, and complications
  • Bone health in prostate cancer
  • Castration resistant prostate cancer: role of chemotherapy
  • Antiandrogen monotherapy in the treatment of prostate cancer
  • Sipuleucel-T
  • a model for immunotherapy trial development
  • Second-line hormonal for castrate-resistant prostate cancer
  • Salvage cryoablation of the prostate
  • High-intensity focused ultrasound
  • Focal therapy for prostate cancer
  • Quality of life: impact of prostate cancer and its treatment
  • Impact of prostate cancer treatments on sexual health
  • Coding and billing for diagnosis and treatment of prostate cancer
  • Health policy for prostate cancer: PSA screening as case study
  • Legal implications of prostate cancer screening
  • New markers for prostate cancer detection and prognosis
  • Testosterone therapy in hypogonadal men with prostate cancer.